Table of Content

1 Market Overview

• 1.1 Market Segment Overview
  • 1.1.1 Product Definition
  • 1.1.2 Market by Drug Class
    • 1.1.2.1 C1-inhibitors
    • 1.1.2.2 Kallikrein Inhibitor (Kalbitor)
    • 1.1.2.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
  • 1.1.3 Market by Application
    • 1.1.3.1 Hospital Pharmacies
    • 1.1.3.2 Independent Pharmacies and Outlets
• 1.2 Global and China Market Size
  • 1.2.1 Global Overview
  • 1.2.2 China Overview

2 Global and China Market by Company

• 2.1 Global
  • 2.1.1 Global Sales by Company
  • 2.1.2 Global Price by Company
• 2.2 China
  • 2.2.1 China Sales by Company
  • 2.2.2 China Price by Company

3 Global and China Market by Drug Class

• 3.1 Global
  • 3.1.1 Global Sales by Drug Class
  • 3.1.2 Global Price by Drug Class
• 3.2 China
  • 3.2.1 China Sales by Drug Class
  • 3.2.2 China Price by Drug Class

4 Global and China Market by Application

• 4.1 Global
  • 4.1.1 Global Sales by Application
  • 4.1.2 Global Price by Application
• 4.2 China
  • 4.2.1 China Sales by Application
  • 4.2.2 China Price by Application

5 China Trade

• 5.1 Export
• 5.2 Import

6 Key Manufacturers

• 6.1 Shire plc
  • 6.1.1 Company Information
  • 6.1.2 Product Specifications
  • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 6.2 CSL Limited
• 6.3 Sanquin
• 6.4 Pharming Group N.V.

7 Industry Upstream

• 7.1 Industry Chain
• 7.2 Raw Materials

8 Market Environment

• 8.1 SWOT
• 8.2 Porter's Five Forces

9 Conclusion

Summary

Market Segment as follows:
By Type
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)
Selective Bradykinin B2 Receptor Antagonist (Firazyr)
By Application
Hospital Pharmacies
Independent Pharmacies and Outlets
By Company
Shire plc
CSL Limited
Sanquin
Pharming Group N.V.
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by Drug Class;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.